Thermo Fisher Scientific Inc. (TMO), a life sciences and clinical research company, on Thursday reported that net income increased in the fourth quarter compared with the previous year.
For the fourth quarter, net income attributable to the company rose to $1.96 billion from $1.83 billion in the previous year.
Earnings per share were $5.21 versus $4.78 last year.
Adjusted net income increased to $2.48 billion from $2.34 billion in the previous year.
Adjusted earnings per share were $6.57 versus $6.10 last year.
Operating income jumped to $2.26 billion from $2.02 billion in the prior year.
Revenue increased to $12.22 billion from $11.40 billion in the previous year.
In the pre-market trading, 1.42% higher at $616.98 on the New York Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.